Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription Articles published in Ann Surg Retrieve available abstracts of 79 articles: HTML format

Single Articles

December 2021
1. POULSON M, Geary AD, Annesi C, Dechert T, et al
   The Impact of Income and Social Mobility on Colorectal Cancer Outcomes and Treatment: A Cross-sectional Study.
   Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93134.
   PubMed     Abstract available
   
   
   
2. PYO DH, Kim SH, Ha SY, Yun SH, et al
   Revised Nodal Staging Integrating Tumor Deposit Counts With Positive Lymph Nodes in Patients With Stage III Colon Cancer.
   Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93132.
   PubMed     Abstract available
   
   
   
3. LU C, Schardey J, Zhang T, Crispin A, et al
   Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-Associated Colorectal Cancer: A Systematic Review and Meta-Analysis.
   Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93150.
   PubMed     Abstract available
   
   
   
4. LAMBERT J, Hayes L, Keegan T, Subar D, et al
   Response to the Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-analysis".
   Ann Surg. 2021;274:e932-e933.
   PubMed    
   
   
   
5. ONERUP A, Angenete E, Haglind E
   Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-accordant Meta-analysis".
   Ann Surg. 2021;274:e932.
   PubMed    
   
   
   
6. WANG J, Andreatos N, Margonis GA
   Comment on "RAS/TP53 co-Mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease".
   Ann Surg. 2021;274:e935-e936.
   PubMed    
   
   
   
7. SHINALL MC JR, Beskow LM, Karlekar M, Martin SF, et al
   Psychosocial Stress Before Major Oncologic Operations: A Qualitative Content Analysis of Palliative Care Provider Documentation.
   Ann Surg. 2021;274:e649-e650.
   PubMed    
   
   
   
8. LAMAZZA A, Carati M, Fiori E, Sterpetti AV, et al
   Comment on "Endoscopic Stenting and Diverting Colostomy as a Bridge to Surgery for Malignant Colorectal Obstruction." Balance Between Evidence-based Medicine and Personalized Therapy.
   Ann Surg. 2021;274:e874-e875.
   PubMed    
   
   
   
9. ZHOU H, Tang Y, Hu Z
   Comment on "Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer".
   Ann Surg. 2021;274:e724.
   PubMed    
   
   
   
10. WEI B, Zheng Z, Fang J, Xiao J, et al
    Effect of Denonvilliers' Fascia Preservation Versus Resection During Laparoscopic Total Mesorectal Excision on Postoperative Urogenital Function of Male Rectal Cancer Patients: Initial Results of Chinese PUF-01 Randomized Clinical Trial.
    Ann Surg. 2021;274:e473-e480.
    PubMed     Abstract available
    
    
    
11. KAWAGUCHI Y, Newhook TE, Vauthey JN
    Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases".
    Ann Surg. 2021;274:e713-e714.
    PubMed    
    
    
    
12. CRIPPA J, Grass F, Larson DW
    Response to the Comment on "Robotic Surgery for Rectal Cancer Provides Advantageous Outcomes Over Laparoscopic Approach".
    Ann Surg. 2021;274:e740.
    PubMed    
    
    
    
13. ZHANG QX, Xu BB, Xue Z
    Comment on "Robotic Surgery for Rectal Cancer Provides Advantageous Outcomes Over Laparoscopic Approach: Results From a Large Retrospective Cohort".
    Ann Surg. 2021;274:e739-e740.
    PubMed    
    
    
    
14. BERGAMASCHI R, Gachabayov M, Orangio G, Remzi F, et al
    Comment on "Local Recurrence After taTME for Rectal Cancer".
    Ann Surg. 2021;274:e727.
    PubMed    
    
    
    
15. ROODBEEN SX, Spinelli A, Bemelman W, Di Candido F, et al
    Response to the Comment on "Local Recurrence After TaTME for Rectal Cancer".
    Ann Surg. 2021;274:e727-e729.
    PubMed    
    
    
    
16. LANG H, Kloth M, Moehler M, Roth W, et al
    Response to the Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases".
    Ann Surg. 2021;274:e714.
    PubMed    
    
    
    
17. SYN NL, Kabir T, Goh BKP
    Response to the Comment on "Survival Advantage of Laparoscopic Versus Open Resection for Colorectal Liver Metastases".
    Ann Surg. 2021;274:e730-e731.
    PubMed    
    
    
    
18. VAN DER SANDE ME, Beets GL
    Response to the Comment on "Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer".
    Ann Surg. 2021;274:e724-e725.
    PubMed    
    
    
    
19. PAN L, Fang J, Wang Y, Cai X, et al
    Comment on "Survival Advantage of Laparoscopic Versus Open Resection for Colorectal Liver Metastases".
    Ann Surg. 2021;274:e729-e730.
    PubMed    
    
    
    
20. ZHANG QX, Xu BB, Xue Z
    Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer".
    Ann Surg. 2021;274:e689-e690.
    PubMed    
    
    
    
21. BOLTON WS, Chapman SJ, Corrigan N, Croft J, et al
    The Incidence of Low Anterior Resection Syndrome as Assessed in an International Randomized Controlled Trial (MRC/NIHR ROLARR).
    Ann Surg. 2021;274:e1223-e1229.
    PubMed     Abstract available
    
    
    
22. TRILLING B, Girard E, Faucheron JL
    Comment on "Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemoradiotherapy and Resection for Rectal Cancer".
    Ann Surg. 2021;274:e670-e671.
    PubMed    
    
    
    
23. CRIPPA J, Grass F, Dozois EJ, Mathis KL, et al
    Robotic Surgery for Rectal Cancer Provides Advantageous Outcomes Over Laparoscopic Approach: Results From a Large Retrospective Cohort.
    Ann Surg. 2021;274:e1218-e1222.
    PubMed     Abstract available
    
    
    
24. JANG JH, Kim HC
    Response to the Comment on "Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemotherapy and Resection for Rectal Cancer".
    Ann Surg. 2021;274:e671-e672.
    PubMed    
    
    
    
25. VAN DER SANDE ME, Figueiredo N, Beets GL
    Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer.
    Ann Surg. 2021;274:e1056-e1062.
    PubMed     Abstract available
    
    
    
26. VAN DER SANDE ME, Maas M, Melenhorst J, Breukink SO, et al
    Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer.
    Ann Surg. 2021;274:e541-e547.
    PubMed     Abstract available
    
    
    
27. KALTENMEIER C, Shen C, Medich DS, Geller DA, et al
    Time to Surgery and Colon Cancer Survival in the United States.
    Ann Surg. 2021;274:1025-1031.
    PubMed     Abstract available
    
    
    
28. YOON JY, Mehta N, Burke CA, Augustin T, et al
    The Prevalence and Significance of Jejunal and Duodenal Bulb Polyposis After Duodenectomy in Familial Adenomatous Polyposis: Retrospective Cohort Study.
    Ann Surg. 2021;274:e1071-e1077.
    PubMed     Abstract available
    
    
    November 2021
29. AUBERT M, Mege D, Parc Y, Rullier E, et al
    Surgical Management of Retrorectal Tumors: A French Multicentric Experience of 270 Consecutives Cases.
    Ann Surg. 2021;274:766-772.
    PubMed     Abstract available
    
    
    October 2021
30. CHIORESO C, Gao X, Gribovskaja-Rupp I, Lin C, et al
    Hospital and Surgeon Selection for Medicare Beneficiaries With Stage II/III Rectal Cancer: The Role of Rurality, Distance to Care, and Colonoscopy Provider.
    Ann Surg. 2021;274:e336-e344.
    PubMed     Abstract available
    
    
    September 2021
31. LAMBERT J, Hayes L, Keegan T, Subar D, et al
    Response to: (Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal and Upper Gastro-Intestinal Cancer Surgery: A PRISMA-Accordant Meta-Analysis").
    Ann Surg. 2021 Sep 29. pii: 00000658-900000000-93254.
    PubMed    
    
    
    
32. FIORE JF JR, Gillis C, Touma N, Elhaj H, et al
    Comment on: The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-analysis.
    Ann Surg. 2021 Sep 26. pii: 00000658-900000000-93253.
    PubMed    
    
    
    
33. BOSTROM P, Hultberg DK, Haggstrom J, Haapamaki MM, et al
    Oncological Impact of High Vascular Tie After Surgery for Rectal Cancer: A Nationwide Cohort Study.
    Ann Surg. 2021;274:e236-e244.
    PubMed     Abstract available
    
    
    August 2021
34. PLANELLAS P, Marinello F, Elorza G, Golda T, et al
    Extended Versus Standard Complete Mesocolon Excision in Sigmoid Colon Cancer: A Multicentre Randomised Controlled Trial.
    Ann Surg. 2021 Aug 19. pii: 00000658-900000000-93319.
    PubMed     Abstract available
    
    
    
35. BEHMAN R, Chesney T, Coburn N, Haas B, et al
    Minimally Invasive Compared to Open Colorectal Cancer Resection for Older Adults: A Population-based Analysis of Long-term Functional Outcomes.
    Ann Surg. 2021 Aug 19. pii: 00000658-900000000-93311.
    PubMed     Abstract available
    
    
    
36. DONATI M, Zanatta M, Basile F
    Comments on "Strategy for Left sided Ostructive Colon Cancer": are we really writing the Epitaph of the three times approach?
    Ann Surg. 2021 Aug 11. pii: 00000658-900000000-93344.
    PubMed    
    
    
    
37. LEE SY, Lee J, Park HM, Kim CH, et al
    Impact of Preoperative Immunonutrition on the Outcomes of Colon Cancer Surgery: Results from a Randomized Controlled Trial.
    Ann Surg. 2021 Aug 4. pii: 00000658-900000000-93357.
    PubMed     Abstract available
    
    
    
38. YOU YN, Rodriguez-Bigas MA, Das P, Healy M, et al
    Comment on "A National Cancer Database Analysis of Microsatellite Instability and Pathologic Complete Response in Locally Advanced Rectal Cancer".
    Ann Surg. 2021;274:e197-e198.
    PubMed    
    
    
    
39. ROODBEEN SX, Spinelli A, Bemelman WA, Di Candido F, et al
    Local Recurrence After Transanal Total Mesorectal Excision for Rectal Cancer: A Multicenter Cohort Study.
    Ann Surg. 2021;274:359-366.
    PubMed     Abstract available
    
    
    
40. SYLLA P, Knol JJ, D'Andrea AP, Perez RO, et al
    Urethral Injury and Other Urologic Injuries During Transanal Total Mesorectal Excision: An International Collaborative Study.
    Ann Surg. 2021;274:e115-e125.
    PubMed     Abstract available
    
    
    
41. MAO R, Li K, Cai JQ, Luo S, et al
    Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas.
    Ann Surg. 2021;274:e126-e133.
    PubMed     Abstract available
    
    
    July 2021
42. LOUGHREY MB, Webster F, Arends MJ, Brown I, et al
    Dataset for Pathology Reporting of Colorectal Cancer: Recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Ann Surg. 2021 Jul 7. pii: 00000658-900000000-93438.
    PubMed     Abstract available
    
    
    June 2021
43. MARGONIS GA, Amini N, Buettner S, Kim Y, et al
    The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
    Ann Surg. 2021;273:1165-1172.
    PubMed     Abstract available
    
    
    May 2021
44. BALVARDI S, Pecorelli N, Castelino T, Niculiseanu P, et al
    Impact of Facilitation of Early Mobilization on Postoperative Pulmonary Outcomes After Colorectal Surgery: A Randomized Controlled Trial.
    Ann Surg. 2021;273:868-875.
    PubMed     Abstract available
    
    
    April 2021
45. KEMENY NE, Chou JF, Capanu M, Chatila WK, et al
    A Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Therapy with or without Panitumumab after Hepatic Resection of KRAS Wild-Type Colorectal Cancer.
    Ann Surg. 2021 Apr 30. pii: 00000658-900000000-93567.
    PubMed     Abstract available
    
    
    
46. ONERUP A, Andersson J, Angenete E, Bock D, et al
    Effect of Short-Term Homebased Pre- and Postoperative Exercise on Recovery after Colorectal Cancer Surgery (PHYSSURG-C): A Randomized Clinical Trial.
    Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93606.
    PubMed     Abstract available
    
    
    
47. CURTIS NJ, Dennison G, Brown CSB, Hewett PJ, et al
    Clinical Evaluation of Intraoperative Near Misses in Laparoscopic Rectal Cancer Surgery.
    Ann Surg. 2021;273:778-784.
    PubMed     Abstract available
    
    
    March 2021
48. HASSELGREN K, Rosok BI, Larsen PN, Sparrelid E, et al
    ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO.
    Ann Surg. 2021;273:442-448.
    PubMed     Abstract available
    
    
    February 2021
49. ISHIBE A, Watanabe J, Ota M, Endo I, et al
    Response to Comments on "A prospective, single-arm, multicenter trial of diverting stoma followed by neoadjuvant chemotherapy using mFOLFOX6 for obstructive colon cancer: YCOG1305 (PROBE study)".
    Ann Surg. 2021 Feb 26. doi: 10.1097/SLA.0000000000004824.
    PubMed    
    
    
    
50. CAZELLES A, Manceau G, Taieb J, Karoui M, et al
    Comments On "A Prospective, Single-Arm, Multicenter Trial of Diverting Stoma Followed By Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG 1305 (PROBE study)" Ann Surg 2020 [Epub ahead of print]. DOI: 10.1097/SLA.0000000000004
    Ann Surg. 2021 Feb 18. pii: 00000658-900000000-93710.
    PubMed    
    
    
    
51. ZHANG Q, Chen B, Liu ZK
    Comment on "Apical Node Involvement Does Not Influence Prognosis After Potentially Curative Resection for Stage III Colorectal Cancer, A Competing Risks Analysis".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93706.
    PubMed    
    
    
    
52. DI BUONO G, Agrusa A
    Response to: Comment on "Feasibility and safety of laparoscopic Complete Mesocolic Excision (CME) for right-sided colon cancer: short-term outcomes. A randomized clinical study".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93705.
    PubMed    
    
    
    
53. LU JY, Xiao Y
    Comment on "Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-Sided Colon Cancer: Short-term Outcomes. A Randomized Clinical Study".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93703.
    PubMed    
    
    
    
54. STEIN SL
    Measure Twice, Cut Once.
    Ann Surg. 2021;273:195-196.
    PubMed    
    
    
    January 2021
55. WATANABE J, Ishibe A, Suwa H, Ota M, et al
    Long-term Outcomes of a Randomized Controlled Trial of Single-incision Versus Multi-port Laparoscopic Colectomy for Colon Cancer.
    Ann Surg. 2021 Jan 28. doi: 10.1097/SLA.0000000000004252.
    PubMed     Abstract available
    
    
    December 2020
56. QING Z, Liu ZY, Chen QY, Huang CM, et al
    Comment on: Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Dec 29. doi: 10.1097/SLA.0000000000004734.
    PubMed    
    
    
    
57. HEALY MA, Peacock O, Hu CY, Bednarski BK, et al
    High Rate of Positive Circumferential Resection Margin in Colon Cancer: A National Appraisal and Call for Action.
    Ann Surg. 2020 Dec 22. doi: 10.1097/SLA.0000000000004682.
    PubMed     Abstract available
    
    
    
58. OKUGAWA Y, Toiyama Y, Ohi M, Kusunoki M, et al
    Response to the Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    
    
    
    
59. KUDOSE Y, Ahiko Y, Shida D
    Response to: Comment on "Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    
    
    
    
60. WANG X, Zheng Z, Chi P
    Comment on "Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    
    
    
    
61. DENG X, Liu P, Jiang D, Wei M, et al
    Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial.
    Ann Surg. 2020;272:1060-1069.
    PubMed     Abstract available
    
    
    
62. YAMASHITA S, Chun YS, Kopetz SE, Maru D, et al
    APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
    Ann Surg. 2020;272:1080-1085.
    PubMed     Abstract available
    
    
    November 2020
63. POULSON M, Cornell E, Madiedo A, Kenzik K, et al
    The Impact of Racial Residential Segregation on Colorectal Cancer Outcomes and Treatment.
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004653.
    PubMed     Abstract available
    
    
    
64. TRILLING B, Delattre F, Faucheron JL
    Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004403.
    PubMed    
    
    
    
65. GAO Z, Wang C, Jiang K, Shen Z, et al
    Response to the Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results from a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004394.
    PubMed    
    
    
    
66. GAO Z, Wang C, Tao Z, Ye Y, et al
    Response to Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004273.
    PubMed    
    
    
    
67. ZHU D, Xia J, Gu Y, Lin J, et al
    Preoperative Hepatic and Regional Arterial Chemotherapy in Patients Who Underwent Curative Colorectal Cancer Resection: A Prospective, Multi-Center, Randomized Controlled Trial.
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004558.
    PubMed     Abstract available
    
    
    
68. LAMBERT J, Hayes L, Keegan T, Subar D, et al
    The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-Analysis.
    Ann Surg. 2020 Nov 12. doi: 10.1097/SLA.0000000000004527.
    PubMed     Abstract available
    
    
    
69. DI BUONO G, Buscemi S, Cocorullo G, Sorce V, et al
    Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-Sided Colon Cancer: Short-Term Outcomes. A Randomized Clinical Study.
    Ann Surg. 2020 Nov 9. doi: 10.1097/SLA.0000000000004557.
    PubMed     Abstract available
    
    
    
70. PETROWSKY H, Linecker M, Raptis DA, Kuemmerli C, et al
    First Long-term Oncologic Results of the ALPPS Procedure in a Large Cohort of Patients With Colorectal Liver Metastases.
    Ann Surg. 2020;272:793-800.
    PubMed     Abstract available
    
    
    
71. IGNATAVICIUS P, Oberkofler CE, Chapman WC, DeMatteo RP, et al
    Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice?
    Ann Surg. 2020;272:715-722.
    PubMed     Abstract available
    
    
    
72. AREZZO A, Forcignano E, Bonino MA, Balague C, et al
    Long-term Oncologic Results After Stenting as a Bridge to Surgery Versus Emergency Surgery for Malignant Left-sided Colonic Obstruction: A Multicenter Randomized Controlled Trial (ESCO Trial).
    Ann Surg. 2020;272:703-708.
    PubMed     Abstract available
    
    
    October 2020
73. GLEASON F, Chu DI, Kennedy GD, Kenzik KM, et al
    Early Elective Surgery After Colon Cancer Diagnosis has Higher Risk of Readmission and Death.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004431.
    PubMed     Abstract available
    
    
    
74. NG KS, Dent OF, Chan C, Newland RC, et al
    Apical Node Involvement Does Not Influence Prognosis After Potentially Curative Resection for Stage III Colorectal Cancer: A Competing Risks Analysis.
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004353.
    PubMed     Abstract available
    
    
    
75. SOUADKA A, Majbar MA, Essangri H, Benkabbou A, et al
    Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-Year Results From a Prospective, Nonrandomized, Double-Blind, Controlled Trial".
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004284.
    PubMed    
    
    
    July 2020
76. ARRINGTON AK, O'Grady C, Schaefer K, Khreiss M, et al
    Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004181.
    PubMed     Abstract available
    
    
    June 2020
77. DUELAND S, Line PD
    Response to Comment on "Survival Following Liver Transplantation for Patients with Nonresectable Liver-only Colorectal Metastases".
    Ann Surg. 2020 Jun 3. doi: 10.1097/SLA.0000000000003953.
    PubMed    
    
    
    May 2020
78. JEGATHEESWARAN S, Siriwardena AK
    Comment on "Survival After Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases".
    Ann Surg. 2020 May 8. doi: 10.1097/SLA.0000000000003960.
    PubMed    
    
    
    September 2019
79. GORGEN A, Sapisochin G
    Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases": What if Those Lesions are Gone?
    Ann Surg. 2019 Sep 24. doi: 10.1097/SLA.0000000000003606.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: